Clinical Trial Update: Two-Fraction Ultrahypofractionated Radiotherapy With Focal Boost for Intermediate Risk, Localized Prostate Cancer [NA]

View source ↗

Summary

Clinical trial evaluating two-fraction ultrahypofractionated radiotherapy with a focal boost for intermediate-risk localized prostate cancer is currently recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: UMC Utrecht | Conditions: Prostate Cancer, Prostate Adenocarcinoma | NA | Status: RECRUITING